Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.

Schuetze SM, Bolejack V, Thomas DG, von Mehren M, Patel S, Samuels B, Choy E, D'Amato G, Staddon AP, Ganjoo KN, Chow WA, Rushing DA, Forscher CA, Priebat DA, Loeb DM, Chugh R, Okuno S, Reinke DK, Baker LH.

JAMA Oncol. 2018 Jun 1;4(6):814-820. doi: 10.1001/jamaoncol.2018.0601.

PMID:
29710216
2.

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.

Higham CS, Steinberg SM, Dombi E, Perry A, Helman LJ, Schuetze SM, Ludwig JA, Staddon A, Milhem MM, Rushing D, Jones RL, Livingston M, Goldman S, Moertel C, Wagner L, Janhofer D, Annunziata CM, Reinke D, Long L, Viskochil D, Baker L, Widemann BC.

Sarcoma. 2017;2017:8685638. doi: 10.1155/2017/8685638. Epub 2017 Sep 12.

3.

Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.

Starczak Y, Reinke DC, Barratt KR, Ryan JW, Russell PK, Clarke MV, St-Arnaud R, Morris HA, Davey RA, Atkins GJ, Anderson PH.

J Steroid Biochem Mol Biol. 2018 Mar;177:77-82. doi: 10.1016/j.jsbmb.2017.10.022. Epub 2017 Oct 28.

PMID:
29107736
4.

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S.

Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711. Lancet Oncol. 2018 Jan;19(1):e8.

PMID:
28988646
5.

Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice.

Reinke DC, Starczak Y, Kogawa M, Barratt KR, Morris HA, Anderson PH, Atkins GJ.

J Steroid Biochem Mol Biol. 2018 Mar;177:96-102. doi: 10.1016/j.jsbmb.2017.07.033. Epub 2017 Jul 29.

PMID:
28765041
6.

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.

Tap WD, Papai Z, Van Tine BA, Attia S, Ganjoo KN, Jones RL, Schuetze S, Reed D, Chawla SP, Riedel RF, Krarup-Hansen A, Toulmonde M, Ray-Coquard I, Hohenberger P, Grignani G, Cranmer LD, Okuno S, Agulnik M, Read W, Ryan CW, Alcindor T, Del Muro XFG, Budd GT, Tawbi H, Pearce T, Kroll S, Reinke DK, Schöffski P.

Lancet Oncol. 2017 Aug;18(8):1089-1103. doi: 10.1016/S1470-2045(17)30381-9. Epub 2017 Jun 23. Erratum in: Lancet Oncol. 2018 Feb;19(2):e78.

PMID:
28651927
7.

Clinical trial enrollment of adolescents and young adults with sarcoma.

Davis LE, Janeway KA, Weiss AR, Chen YE, Scharschmidt TJ, Krailo M, Glade Bender JL, Kopp LM, Patel SR, Schwartz GK, Horvath LE, Hawkins DS, Chuk MK, Reinke DK, Gorlick RG, Randall RL.

Cancer. 2017 Sep 15;123(18):3434-3440. doi: 10.1002/cncr.30757. Epub 2017 May 11. Review.

8.

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.

Schuetze SM, Bolejack V, Choy E, Ganjoo KN, Staddon AP, Chow WA, Tawbi HA, Samuels BL, Patel SR, von Mehren M, D'Amato G, Leu KM, Loeb DM, Forscher CA, Milhem MM, Rushing DA, Lucas DR, Chugh R, Reinke DK, Baker LH.

Cancer. 2017 Jan 1;123(1):90-97. doi: 10.1002/cncr.30379. Epub 2016 Oct 3.

9.

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

Koshkin VS, Bolejack V, Schwartz LH, Wahl RL, Chugh R, Reinke DK, Zhao B, O JH, Patel SR, Schuetze SM, Baker LH.

J Clin Oncol. 2016 Aug 29. pii: JCO681858. [Epub ahead of print]

10.

The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report.

Kager L, Whelan J, Dirksen U, Hassan B, Anninga J, Bennister L, Bovée JVMG, Brennan B, Broto JM, Brugières L, Cleton-Jansen AM, Copland C, Dutour A, Fagioli F, Ferrari S, Fiocco M, Fleuren E, Gaspar N, Gelderblom H, Gerrand C, Gerß J, Gonzato O, van der Graaf W, Hecker-Nolting S, Herrero-Martín D, Klco-Brosius S, Kovar H, Ladenstein R, Lancia C, LeDeley MC, McCabe MG, Metzler M, Myklebost O, Nathrath M, Picci P, Potratz J, Redini F, Richter GHS, Reinke D, Rutkowski P, Scotlandi K, Strauss S, Thomas D, Tirado OM, Tirode F, Vassal G, Bielack SS.

Clin Sarcoma Res. 2016 Mar 16;6:3. doi: 10.1186/s13569-016-0043-5. eCollection 2016.

11.

Gastrointestinal stromal tumor with an unusual presentation as an enlarged prostate gland: a case report and review of the literature.

Reinke DA, Deisch JK, Reinke DD.

J Gastrointest Oncol. 2016 Apr;7(Suppl 1):S71-4. doi: 10.3978/j.issn.2078-6891.2015.023.

12.

Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

Hyun O J, Luber BS, Leal JP, Wang H, Bolejack V, Schuetze SM, Schwartz LH, Helman LJ, Reinke D, Baker LH, Wahl RL.

J Nucl Med. 2016 May;57(5):735-40. doi: 10.2967/jnumed.115.162412. Epub 2016 Jan 21.

13.

SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.

Schuetze SM, Wathen JK, Lucas DR, Choy E, Samuels BL, Staddon AP, Ganjoo KN, von Mehren M, Chow WA, Loeb DM, Tawbi HA, Rushing DA, Patel SR, Thomas DG, Chugh R, Reinke DK, Baker LH.

Cancer. 2016 Mar 15;122(6):868-74. doi: 10.1002/cncr.29858. Epub 2015 Dec 28.

14.

Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.

Reinke DC, Kogawa M, Barratt KR, Morris HA, Anderson PH, Atkins GJ.

J Steroid Biochem Mol Biol. 2016 Nov;164:353-360. doi: 10.1016/j.jsbmb.2015.11.015. Epub 2015 Nov 27.

PMID:
26639637
15.

A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.

Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM.

Eur J Cancer. 2015 Sep;51(13):1794-802. doi: 10.1016/j.ejca.2015.05.010. Epub 2015 Jun 9.

PMID:
26066736
16.

Herbal substance, acteoside, alleviates intestinal mucositis in mice.

Reinke D, Kritas S, Polychronopoulos P, Skaltsounis AL, Aligiannis N, Tran CD.

Gastroenterol Res Pract. 2015;2015:327872. doi: 10.1155/2015/327872. Epub 2015 Jan 5.

17.

Toward a drug development path that targets metastatic progression in osteosarcoma.

Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, Weigel B, Randall L, Withrow SJ, Paoloni M, Kaplan R, Teicher BA, Seibel NL, Smith M, Uren A, Patel SR, Trent J, Savage SA, Mirabello L, Reinke D, Barkaukas DA, Krailo M, Bernstein M.

Clin Cancer Res. 2014 Aug 15;20(16):4200-9. doi: 10.1158/1078-0432.CCR-13-2574. Epub 2014 May 6.

18.

Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts.

Ryan JW, Reinke D, Kogawa M, Turner AG, Atkins GJ, Anderson PH, Morris HA.

Curr Drug Targets. 2013 Dec;14(14):1683-8. Review.

PMID:
24010964
19.

Cancer- and chemotherapy-induced anemia.

Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B, Gilreath JA, Kraut EH, Matulonis UA, Millenson MM, Reinke D, Rosenthal J, Schwartz RN, Soff G, Stein RS, Vlahovic G, Weir AB 3rd.

J Natl Compr Canc Netw. 2012 May;10(5):628-53.

PMID:
22570293
20.

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.

Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ.

Oncologist. 2012;17(3):321. doi: 10.1634/theoncologist.2010-0265. Epub 2012 Feb 23.

21.

Sulphur diagenesis in the sediments of the Kiel Bight, SW Baltic Sea, as reflected by multiple stable sulphur isotopes.

Strauss H, Bast R, Cording A, Diekrup D, Fugmann A, Garbe-Schönberg D, Lutter A, Oeser M, Rabe K, Reinke D, Teichert BM, Westernströer U.

Isotopes Environ Health Stud. 2012;48(1):166-79. doi: 10.1080/10256016.2012.648930. Epub 2012 Feb 6.

PMID:
22303924
22.

R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.

Pappo AS, Patel SR, Crowley J, Reinke DK, Kuenkele KP, Chawla SP, Toner GC, Maki RG, Meyers PA, Chugh R, Ganjoo KN, Schuetze SM, Juergens H, Leahy MG, Geoerger B, Benjamin RS, Helman LJ, Baker LH.

J Clin Oncol. 2011 Dec 1;29(34):4541-7. doi: 10.1200/JCO.2010.34.0000. Epub 2011 Oct 24.

23.

NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.

Zelenetz AD, Ahmed I, Braud EL, Cross JD, Davenport-Ennis N, Dickinson BD, Goldberg SE, Gottlieb S, Johnson PE, Lyman GH, Markus R, Matulonis UA, Reinke D, Li EC, DeMartino J, Larsen JK, Hoffman JM.

J Natl Compr Canc Netw. 2011 Sep;9 Suppl 4:S1-22.

PMID:
21976013
24.

Practical management of imatinib in gastrointestinal stromal tumors.

Barnes T, Reinke D.

Clin J Oncol Nurs. 2011 Oct;15(5):533-45. doi: 10.1188/11.CJON.533-545. Review.

PMID:
21951740
25.

Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model.

Chugh R, Wathen JK, Maki RG, Benjamin RS, Patel SR, Meyers PA, Priebat DA, Reinke DK, Thomas DG, Keohan ML, Samuels BL, Baker LH.

J Clin Oncol. 2009 Jul 1;27(19):3148-53. doi: 10.1200/JCO.2008.20.5054. Epub 2009 May 18. Erratum in: J Clin Oncol. 2009 Sep 20;27(27):4630. Myers, Paul A [corrected to Meyers, Paul A].

PMID:
19451433
26.

Predictors of pediatric emergency patients discharged against medical advice.

Reinke DA, Walker M, Boslaugh S, Hodge D 3rd.

Clin Pediatr (Phila). 2009 Apr;48(3):263-70. doi: 10.1177/0009922808323109. Epub 2008 Oct 2.

PMID:
18832530
27.

Cancer- and chemotherapy-induced anemia.

Rodgers GM 3rd, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2008 Jul;6(6):536-64. No abstract available.

PMID:
18597709
28.

NCCN Task Force Report: Oral chemotherapy.

Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, Muller RJ, Newcomer LN, O'Brien S, Reinke D, Rubino M, Saltz L, Walters RS.

J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1-14. Review.

PMID:
18377852
29.

Errata to "A study of cloud classification with neural networks using spectral and textural features".

Tian B, Shaikh MA, Azimi-Sadjadi MR, Vonder Haar TH, Reinke DL.

IEEE Trans Neural Netw. 1999;10(3):722. doi: 10.1109/TNN.1999.761731. No abstract available.

PMID:
18252572
30.

A study of cloud classification with neural networks using spectral and textural features.

Tian B, Shaikh MA, Azimi-Sadjadi MR, Haar TV, Reinke DL.

IEEE Trans Neural Netw. 1999;10(1):138-51. doi: 10.1109/72.737500.

PMID:
18252510
31.

Temporal updating scheme for probabilistic neural network with application to satellite cloud classification--further results.

Azimi-Sadjadi MR, Gao W, Vonder Haar TH, Reinke D.

IEEE Trans Neural Netw. 2001;12(5):1196-203. doi: 10.1109/72.950147.

PMID:
18249945
32.

Temporal updating scheme for probabilistic neural network with application to satellite cloud classification.

Tian B, Azimi-Sadjadi MR, Vonder Haar TH, Reinke D.

IEEE Trans Neural Netw. 2000;11(4):903-20. doi: 10.1109/72.857771.

PMID:
18249818
33.

A review of anemia management in the oncology setting: a focus on implementing standing orders.

Mickle J, Reinke D.

Clin J Oncol Nurs. 2007 Aug;11(4):534-9. Review.

PMID:
17723966
34.

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML.

J Clin Oncol. 2007 Jul 1;25(19):2755-63. Erratum in: J Clin Oncol. 2007 Aug 20;25(24):3790.

PMID:
17602081
35.

Noncentral forces in crystals of charged colloids.

Reinke D, Stark H, von Grünberg HH, Schofield AB, Maret G, Gasser U.

Phys Rev Lett. 2007 Jan 19;98(3):038301. Epub 2007 Jan 19.

PMID:
17358736
36.

Comment on "Evidence of many-particle interactions in two-dimensional charge-stabilized colloidal crystals".

Reinke D.

Phys Rev Lett. 2006 Sep 15;97(11):119801. Epub 2006 Sep 13. No abstract available.

PMID:
17025939
37.

Cancer- and treatment-related anemia.

Rodgers GM 3rd, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Demetri GD, Djulbegovic B, Garst JL, Gore M, Kraut EH, Lin WC, Millenson M, Mock V, Reinke D, Rosenthal J, Sabbatini P.

J Natl Compr Canc Netw. 2005 Nov;3(6):772-89. No abstract available.

PMID:
16316613
38.

A temporally adaptive classifier for multispectral imagery.

Wang J, Azimi-Sadjadi MR, Reinke D.

IEEE Trans Neural Netw. 2004 Jan;15(1):159-65.

PMID:
15387256
39.

Measurement of the magneto-optical correlation length in turbid media.

Lenke R, Eisenmann C, Reinke D, Maret G.

Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Nov;66(5 Pt 2):056610. Epub 2002 Nov 22.

PMID:
12513626
40.

Immediate repair compared with surveillance of small abdominal aortic aneurysms.

Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, Ballard DJ, Messina LM, Gordon IL, Chute EP, Krupski WC, Busuttil SJ, Barone GW, Sparks S, Graham LM, Rapp JH, Makaroun MS, Moneta GL, Cambria RA, Makhoul RG, Eton D, Ansel HJ, Freischlag JA, Bandyk D; Aneurysm Detection and Management Veterans Affairs Cooperative Study Group.

N Engl J Med. 2002 May 9;346(19):1437-44.

41.

Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators.

Lederle FA, Johnson GR, Wilson SE, Gordon IL, Chute EP, Littooy FN, Krupski WC, Bandyk D, Barone GW, Graham LM, Hye RJ, Reinke DB.

J Vasc Surg. 1997 Oct;26(4):595-601.

42.

Variability in measurement of abdominal aortic aneurysms. Abdominal Aortic Aneurysm Detection and Management Veterans Administration Cooperative Study Group.

Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, Messina LM, Ballard DJ, Ansel HJ.

J Vasc Surg. 1995 Jun;21(6):945-52.

43.

Use of titanium implants in pedicular screw fixation.

Ebraheim NA, Rupp RE, Savolaine ER, Reinke D.

J Spinal Disord. 1994 Dec;7(6):478-86.

PMID:
7873844
44.

Design of the abdominal aortic Aneurysm Detection and Management Study. ADAM VA Cooperative Study Group.

Lederle FA, Wilson SE, Johnson GR, Littooy FN, Acher C, Messina LM, Reinke DB, Ballard DJ.

J Vasc Surg. 1994 Aug;20(2):296-303.

PMID:
8040955
45.

Seasonal change in the temporal organization of wheel-running activity of the European hamster, Cricetus cricetus.

Wollnik F, Breit A, Reinke D.

Naturwissenschaften. 1991 Sep;78(9):419-22. No abstract available.

PMID:
1961252
46.

Selective screening for abdominal aortic aneurysms with physical examination and ultrasound.

Lederle FA, Walker JM, Reinke DB.

Arch Intern Med. 1988 Aug;148(8):1753-6.

PMID:
3041938
47.

Mycotic aneurysm of the renal artery: CT appearance.

Stavas JM, Reinke DB, Miller RP.

Br J Radiol. 1986 Apr;59(700):401-3. No abstract available.

PMID:
3754475
48.

Hepatobiliary imaging: the diagnostic use of intravenous morphine in fasting patients.

Grund FM, Reinke DB, Larson BW, Shafer RB.

Am J Physiol Imaging. 1986;1(1):26-32.

PMID:
3451754
49.

Detailed caliceal anatomy for endourology.

Kaye KW, Reinke DB.

J Urol. 1984 Dec;132(6):1085-8.

PMID:
6502793
50.

Pursuit of the renal mass. Is ultrasound enough?

Clayman RV, Surya V, Miller RP, Reinke DB, Fraley EE.

Am J Med. 1984 Aug;77(2):218-23.

PMID:
6465172

Supplemental Content

Loading ...
Support Center